©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 27, 2024; 16(6): 878-882
Published online Jun 27, 2024. doi: 10.4254/wjh.v16.i6.878
Published online Jun 27, 2024. doi: 10.4254/wjh.v16.i6.878
Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Stanislav Kotlyarov, Department of Nursing, Ryazan State Medical University, Ryazan 390026, Russia
Author contributions: Kotlyarov S conceptualization, methodology, validation, resources, data curation, writing-original draft preparation, writing-review and editing, supervision, project administration.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Corresponding author: Stanislav Kotlyarov, PhD, Academic Research, Department of Nursing, Ryazan State Medical University, Vysokovoltnaya St. 9, Ryazan 390026, Russia.
Received: March 3, 2024
Revised: May 1, 2024
Accepted: May 17, 2024
Published online: June 27, 2024
Processing time: 108 Days and 17.4 Hours
Revised: May 1, 2024
Accepted: May 17, 2024
Published online: June 27, 2024
Processing time: 108 Days and 17.4 Hours
Core Tip
Core Tip: The gut microbiota plays an important immune and metabolic role in the body both under physiologic conditions and in the development of various liver diseases. The gut microbiota is involved in the production of various substances such as short-chain fatty acids, which play an important role in linking the gut to other organs. The composition of the gut microbiota may change in various liver diseases, and this relationship is two-way.